HemaSphere (May 2023)

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY

  • K. Groen,
  • C. Stege,
  • K. Nasserinejad,
  • K. de Heer,
  • R. van Kampen,
  • R. Leys,
  • N. Thielen,
  • M. Westerman,
  • K. Wu,
  • I. Ludwig,
  • D. Issa,
  • G. Velders,
  • M. Vekemans,
  • N. van de Donk,
  • G. Timmers,
  • F. de Boer,
  • L. Tick,
  • E. van der Spek,
  • E. de Waal,
  • M. Sohne,
  • P. Sonneveld,
  • I. Nijhof,
  • S. Klein,
  • M. Levin,
  • P. Ypma,
  • S. Zweegman

DOI
https://doi.org/10.1097/01.HS9.0000936180.78583.90
Journal volume & issue
Vol. 7, no. S2
pp. 16 – 17

Abstract

Read online

No abstracts available.